01 / Trauma
Critical minutes
Portable testing concepts for rapid assessment when hemorrhage management is time-sensitive.
Clarity in coagulation, when every minute matters.
CoagCare™ is being developed as a portable point-of-care platform for rapid viscoelastic coagulation assessment.
Explore CoagCare
Rapid hemostasis informationPortable point-of-care designFrom clot formation to fibrinolysisRapid hemostasis informationPortable point-of-care designFrom clot formation to fibrinolysis
CoagCare™ platform
Built for information that cannot wait.
Public descriptions of CoagCare pair a portable meter with a single-use diagnostic card to characterize coagulation from clot formation through fibrinolysis.
<10 minPublicly stated target from clot initiation to key viscoelastic information.
POCDesigned around portable, point-of-care use rather than a fixed central lab.
Where it matters
Made for time-sensitive clinical settings.
CoagCare is being advanced for settings where rapid coagulation information can support therapy and transfusion decisions.
02 / Surgery
Perioperative insight
Coagulation information designed to help clinicians understand evolving hemostasis during care.
03 / Critical care
Closer to the bedside
A portable platform direction intended to reduce the distance between sample, measurement and decision.
Viscoelastic signal concept
See coagulation as a changing signal.
CoagCare is publicly described as tracking coagulation from clot formation through clot strength and fibrinolysis. This motion graphic turns that changing response into a single visual story without inventing clinical thresholds or patient data.
Clot formationClot strengthFibrinolysis
CoagCare / signal viewIllustrative profile
01Clot begins to form
02Mechanical response develops
03Breakdown becomes visible
<10minutes stated in 2026 public descriptions for coagulation characterization.
1single-use diagnostic card format paired with a portable meter.
3key clinical contexts highlighted publicly: trauma, surgery and critical care.
Development
From research platform to clinical milestones.
Abram Scientific is advancing CoagCare toward clinical milestones and U.S. FDA 510(k) clearance, according to the company's February 2026 announcement.